Inventor · disambiguated record
Gong Li
Also filed as: LI GONG
13 granted patents·2 pending applications·68 citations·filing 2010–2024
89Inventor score
Files withBEIJING TIDE PHARMACEUTICAL CO LTD11BEIJING HANMI PHARMACEUTICAL CO LTD2BEIJING AVISTONE BIOTECHNOLOGY CO LTD1LI GONG1
Top patents by PatentIndex Score
15 records- 0195US11919918B2P2X3 andor P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2022·Granted Mar 5, 2024·6 cites·20 claims
- 0293US11390609B2Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2018·Granted Jul 19, 2022·12 cites·28 claims
- 0393US10329282B2Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2017·Granted Jun 25, 2019·13 cites·45 claims
- 0493US10323023B2Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2017·Granted Jun 18, 2019·14 cites·71 claims
- 0589US11414444B2P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2018·Granted Aug 16, 2022·5 cites·15 claims
- 0685US9840517B2Compound inhibiting activities of BTK and/or JAK3 kinasesBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2014·Granted Dec 12, 2017·12 cites·6 claims
- 0783US10273242B2Compound inhibiting activities of BTK and/or JAK3 kinasesBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2017·Granted Apr 30, 2019·6 cites·9 claims
- 0880US12509479B2P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2024·Granted Dec 30, 2025·0 cites·17 claims
- 0967US11939578B2Double-stranded RNA molecule targeting CKIP-1 and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2021·Granted Mar 26, 2024·0 cites·14 claims
- 1062US11155819B2Double-stranded RNA molecule targeting CKIP-1 and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2018·Granted Oct 26, 2021·0 cites·20 claims
- 1162US2023030115A1Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1250US2025092033A1Heteroaromatic nitrogen-oxide compound, preparation method therefor, and use thereofBEIJING AVISTONE BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 1346US12398118B2Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2019·Granted Aug 26, 2025·0 cites·13 claims
- 1443US11905274B2Receptor inhibitors, pharmaceutical compositions comprising the same and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2019·Granted Feb 20, 2024·0 cites·44 claims
- 1532US8644715B2Method and device for monitoring and controlling phase difference based on DQPSK modulationLI GONG·Filed 2010·Granted Feb 4, 2014·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Gong Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →